Laman UtamaINCY • NASDAQ
add
Incyte Corp
Tutup sebelumnya
$73.13
Julat hari
$69.53 - $72.60
Julat tahun
$50.35 - $83.94
Permodalan pasaran
13.59B USD
Bilangan Purata
1.79J
Nisbah P/E
504.04
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.14B | 23.81% |
Perbelanjaan pengendalian | 308.47J | 15.48% |
Pendapatan bersih | 106.46J | -37.84% |
Margin untung bersih | 9.36 | -49.79% |
Pendapatan bagi setiap syer | 1.07 | -2.73% |
EBITDA | 192.75J | -18.48% |
Kadar cukai berkesan | 31.99% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.77B | -49.53% |
Jumlah aset | 5.01B | -21.54% |
Jumlah liabiliti | 1.84B | 26.39% |
Jumlah ekuiti | 3.17B | — |
Syer tertunggak | 192.65J | — |
Harga kepada buku | 4.45 | — |
Pulangan pada aset | 8.80% | — |
Pulangan pada modal | 13.64% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 106.46J | -37.84% |
Tunai daripada operasi | 310.87J | 110.28% |
Tunai daripada pelaburan | 38.27J | 322.67% |
Tunai daripada pembiayaan | -32.35J | 13.17% |
Perubahan bersih dalam tunai | 316.92J | 229.77% |
Aliran tunai bebas | 367.45J | 138.29% |
Perihal
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland.
The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufacturers prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Diasaskan
2002
Ibu pejabat
Tapak web
Pekerja
2,524
